Polyclonal Rabbit anti‑Human UGCG Antibody (APC,Cy7, aa39‑171, WB) LS‑C733290
Polyclonal Rabbit anti‑Human UGCG Antibody (APC,Cy7, aa39‑171, WB) LS‑C733290
Antibody:
UGCG Rabbit anti-Human Polyclonal (aa39-171) (APC, Cy7) Antibody
Format:
Allophycocyanin, Cy7, Unmodified
Overview
Antibody:
UGCG Rabbit anti-Human Polyclonal (aa39-171) (APC, Cy7) Antibody
Format:
Allophycocyanin, Cy7, Unmodified
Specifications
Description
UGCG antibody LS-C733290 is an APC, Cy7-conjugated rabbit polyclonal antibody to UGCG (aa39-171) from human. It is reactive with human and mouse. Validated for WB.
Target
Human UGCG
Synonyms
UGCG | Ceramide glucosyl transferase | GLCT1 | Glucosylceramide synthase | GLCT-1 | Ceramide glucosyltransferase | GCS
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Allophycocyanin, Cy7.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
Cy3,
HRP,
APC,
PE.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant UGCG (Lys39-Leu171)
Specificity
The antibody is a rabbit polyclonal antibody raised against UGCG.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot
Species:
Human, Mouse, Rat, Bovine, Pig
Applications:
Western blot
Reactivity:
Human
Range:
0.78-50 ng/ml
Species:
Applications:
ICC, Immunofluorescence, Flow Cytometry
Species:
Human
Applications:
Western blot, Flow Cytometry, ELISA
Reactivity:
Human
Range:
0.31-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/31/2024